Skip to main content
. 2022 Apr 5;9:843987. doi: 10.3389/fsurg.2022.843987

Table 6.

Immune related adverse effect.

Grade I Grade II
Cutaneous rash 5 (45.5%) 1 (9.1%)
Fatigue 3 (27.3%) 0
Nausea 1 (9.1%) 0
Reactive cutaneouscapillary endothelial proliferation 3 (27.3%) 1 (9.1%)
Anemia 1 (9.1%) 1 (9.1%)
Liver malfunction 2 (18.2%) 0
Pruritus 1 (9.1%) 0